IPO Calendar
Lead Manager
- J P Morgan Chase (482)
- Goldman Sachs (458)
- Morgan Stanley (413)
- Bank of America Merrill Lynch (354)
- Citigroup (222)
- Jefferies (211)
- Credit Suisse (180)
- Barclays (150)
- Cowen and Company (145)
- Deutsche Bank (81)
- Piper Jaffray (70)
- Leerink Partners (69)
- Stifel (65)
- UBS Investment Bank (52)
- Evercore (51)
- RBC Capital (50)
- BMO Capital (49)
- Wells Fargo (45)
- William Blair (37)
- Raymond James (36)
More +
IPO - Pricing (11)
Leerink Partners
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 | 908 Devices Inc | Health-Care | 20 | 6 | COWN | LRNK | Stifel | 64.9% | 145% | ||
| Dec 4 | Silverback Ther | Health-Care | 21 | 11 | GS | LRNK | Stifel | 31% | 19% | ||
| Dec 3 | Kinnate BioPhar | Health-Care | 20 | 12 | GS | LRNK | PPRJ | 5.3% | 117.3% | ||
| Oct 29 | Galecto Inc. | Health-Care | 15 | 5 | BAML | LRNK | CS | 23.4% | 0% | ||
| Sep 25 | Graybug Vision | Health-Care | 16 | 5 | LRNK | SNDL | 34.6% | 3.1% | |||
| Jul 30 | AlloVir Inc. | Health-Care | 17 | 16 | MS | JPM | LRNK | 2.5% | 46.5% | ||
| Jul 24 | iTeos Therapeut | Health-Care | 19 | 10 | JPM | LRNK | 22.2% | 0.3% | |||
| Jun 19 | Forma Therapeut | Health-Care | 20 | 13 | JEFF | LRNK | CS | 11.3% | 95% | ||
| Jun 5 | Applied Molecul | Health-Care | 14 | 11 | BAML | JEFF | LRNK | 31.6% | 28.4% | ||
| Apr 8 | Keros Therapeut | Health-Care | 16 | 6 | JEFF | LRNK | 17.7% | 25.5% | |||
| Mar 12 | IMARA Inc. | Health-Care | 16 | 4 | MS | CITI | LRNK | 9.7% | -6.3% | ||
*
Lead manager or one of top three managers in an underwriting team.